✦ LIBER ✦

The development and evaluation of a macrophage model of Gaucher disease

✍ Scribed by Moaven, Nima; Aflaki, Elma; Stubblefield, Barbara K.; Lopez, Grisel; Maniwang, Emerson; Westbroek, Wendy; Tayebi, Nahid; Marugan, Juan; Sidransky, Ellen

Book ID: 122430549
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 59 KB
Volume: 108
Category: Article
ISSN: 1096-7192
DOI: 10.1016/j.ymgme.2012.11.172

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Secondary sphingolipid accumulation in a

Secondary sphingolipid accumulation in a macrophage model of Gaucher disease

✍ Leanne K. Hein; Peter J. Meikle; John J. Hopwood; Maria Fuller 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 207 KB

33. Development of a novel ingestible ma

33. Development of a novel ingestible macrophage-targeted gene therapy for Gaucher disease

✍ Edward Ginns; Arlene Lim; Marzena Galdzicka; Deborah Faryna; Gary Ostroff 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 43 KB

A model of neuronopathic Gaucher disease

✍ P. E. Campbell; C. M. Harris; T. Sirimanna; A. Vellodi 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 95 KB

Laboratory and genetic evaluation of Gau

Laboratory and genetic evaluation of Gaucher disease

✍ Olaf A. Bodamer; Christina Hung 📂 Article 📅 2010 🏛 Springer Vienna 🌐 German ⚖ 130 KB

Impaired IL-10 transcription and release

Impaired IL-10 transcription and release in animal models of Gaucher disease macrophages

✍ Yaacov Kacher; Anthony H. Futerman 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 328 KB

Development of novel therapies in murine

Development of novel therapies in murine models for Gaucher disease

✍ Ida Berglin Enquist; Eva Nilsson; Christophe Lo Bianco; Jan-Eric Månsson; Mats E 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 310 KB